Your browser doesn't support javascript.
loading
Structural brain abnormalities in schizophrenia in adverse environments: examining the effect of poverty and violence in six Latin American cities.
Crossley, Nicolas A; Zugman, Andre; Reyes-Madrigal, Francisco; Czepielewski, Leticia S; Castro, Mariana N; Diaz-Zuluaga, Ana M; Pineda-Zapata, Julian A; Reckziegel, Ramiro; Gadelha, Ary; Jackowski, Andrea; Noto, Cristiano; Alliende, Luz M; Iruretagoyena, Barbara; Ossandon, Tomas; Ramirez-Mahaluf, Juan P; Castañeda, Carmen P; Gonzalez-Valderrama, Alfonso; Nachar, Ruben; León-Ortiz, Pablo; Undurraga, Juan; López-Jaramillo, Carlos; Guinjoan, Salvador M; Gama, Clarissa S; de la Fuente-Sandoval, Camilo; Bressan, Rodrigo A.
Afiliação
  • Crossley NA; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile; Biomedical Imaging Center, Pontificia Universidad Católica de Chile, Chile; and Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
  • Zugman A; Laboratório Interdisciplinar de Neurociências Clínicas (LiNC), Department of Psychiatry, Universidade Federal de São Paulo, Brazil.
  • Reyes-Madrigal F; Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico.
  • Czepielewski LS; Department of the Psychology of Development and Personality, Institute of Psychology, Universidade Federal do Rio Grande do Sul, Brazil.
  • Castro MN; Universidad de Buenos Aires and Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Research Group on Neurosciences as applied to Abnormal Behaviour (INAAC Group), Instituto de Neurociencias Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI)-CONICET
  • Diaz-Zuluaga AM; Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Colombia.
  • Pineda-Zapata JA; Research Group, Instituto de Alta Tecnología Médica, Ayudas Diagnósticas SURA, Colombia.
  • Reckziegel R; Laboratory of Molecular Psychiatry, National Science and Technology Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil.
  • Gadelha A; LiNC, Department of Psychiatry, Universidade Federal de São Paulo, Brazil.
  • Jackowski A; LiNC, Department of Psychiatry, Universidade Federal de São Paulo, Brazil.
  • Noto C; LiNC, Department of Psychiatry, Universidade Federal de São Paulo, Brazil.
  • Alliende LM; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile.
  • Iruretagoyena B; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile.
  • Ossandon T; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile; and Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Chile.
  • Ramirez-Mahaluf JP; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile.
  • Castañeda CP; Early Intervention Program, Instituto Psiquiátrico Dr. José Horwitz Barak, Chile.
  • Gonzalez-Valderrama A; Early Intervention Program, Instituto Psiquiátrico Dr. José Horwitz Barak; and School of Medicine, Universidad Finis Terrae, Chile.
  • Nachar R; Early Intervention Program, Instituto Psiquiátrico Dr. José Horwitz Barak, Chile.
  • León-Ortiz P; Medical Education, Instituto Nacional de Neurología y Neurocirugía; and Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico.
  • Undurraga J; Early Intervention Program, Instituto Psiquiátrico Dr. José Horwitz Barak; and Department of Neurology and Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, Chile.
  • López-Jaramillo C; Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia; and Mood Disorders Program, Hospital Universitario San Vicente Fundación, Colombia.
  • Guinjoan SM; Research Group on Neurosciences as applied to Abnormal Behaviour (INAAC Group), FLENI, Argentina; Department of Psychiatry and Mental Health, School of Medicine, Universidad de Buenos Aires; and National Scientific and Technical Research Council, Argentina.
  • Gama CS; Laboratory of Molecular Psychiatry, National Science and Technology Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil.
  • de la Fuente-Sandoval C; Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía; and Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico.
  • Bressan RA; LiNC, Department of Psychiatry, Universidade Federal de São Paulo, Brazil.
Br J Psychiatry ; 218(2): 112-118, 2021 02.
Article em En | MEDLINE | ID: mdl-32807243
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia Tipo de estudo: Clinical_trials / Prognostic_studies Aspecto: Determinantes_sociais_saude Limite: Humans Idioma: En Revista: Br J Psychiatry Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia Tipo de estudo: Clinical_trials / Prognostic_studies Aspecto: Determinantes_sociais_saude Limite: Humans Idioma: En Revista: Br J Psychiatry Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido